| Kathryn Ashley, LICSW | |
|
435 Line Rd, Aberdeen, NJ 07747-1548 | |
| (617) 470-1321 | |
| Not Available |
| Full Name | Kathryn Ashley |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 31 Years |
| Location | 435 Line Rd, Aberdeen, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164967634 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC05816600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thrive Counseling Llc | 0749458420 | 587 |
News Archive
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved patients' cognitive function and demonstrated similar cancer control outcomes, compared to traditional whole-brain radiotherapy with memantine.
YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer related products, today announced the pricing of 35,000,000 common shares at US$2.00 per common share in its previously announced underwritten public offering.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
Studies show that nearly half of all Americans have difficulty understanding health information. Confusing medical directions, such as dosage and timing of prescription medicine, can lead to serious consequences including health setbacks, inappropriate hospital admissions and, sometimes, death. Now, researchers at the University of Missouri School of Health Professions are examining what health care facilities can do to increase patient understanding and positive outcomes.
› Verified 5 days ago
| Entity Name | Neighborhood Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003850488 PECOS PAC ID: 3072402395 Enrollment ID: O20110713000253 |
News Archive
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved patients' cognitive function and demonstrated similar cancer control outcomes, compared to traditional whole-brain radiotherapy with memantine.
YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer related products, today announced the pricing of 35,000,000 common shares at US$2.00 per common share in its previously announced underwritten public offering.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
Studies show that nearly half of all Americans have difficulty understanding health information. Confusing medical directions, such as dosage and timing of prescription medicine, can lead to serious consequences including health setbacks, inappropriate hospital admissions and, sometimes, death. Now, researchers at the University of Missouri School of Health Professions are examining what health care facilities can do to increase patient understanding and positive outcomes.
› Verified 5 days ago
| Entity Name | Thrive Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215181300 PECOS PAC ID: 0749458420 Enrollment ID: O20201026001145 |
News Archive
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved patients' cognitive function and demonstrated similar cancer control outcomes, compared to traditional whole-brain radiotherapy with memantine.
YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer related products, today announced the pricing of 35,000,000 common shares at US$2.00 per common share in its previously announced underwritten public offering.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
Studies show that nearly half of all Americans have difficulty understanding health information. Confusing medical directions, such as dosage and timing of prescription medicine, can lead to serious consequences including health setbacks, inappropriate hospital admissions and, sometimes, death. Now, researchers at the University of Missouri School of Health Professions are examining what health care facilities can do to increase patient understanding and positive outcomes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Ashley, LICSW 435 Line Rd, Aberdeen, NJ 07747-1548 Ph: (617) 470-1321 | Kathryn Ashley, LICSW 435 Line Rd, Aberdeen, NJ 07747-1548 Ph: (617) 470-1321 |
News Archive
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved patients' cognitive function and demonstrated similar cancer control outcomes, compared to traditional whole-brain radiotherapy with memantine.
YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer related products, today announced the pricing of 35,000,000 common shares at US$2.00 per common share in its previously announced underwritten public offering.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
Studies show that nearly half of all Americans have difficulty understanding health information. Confusing medical directions, such as dosage and timing of prescription medicine, can lead to serious consequences including health setbacks, inappropriate hospital admissions and, sometimes, death. Now, researchers at the University of Missouri School of Health Professions are examining what health care facilities can do to increase patient understanding and positive outcomes.
› Verified 5 days ago
Ms. Charise Atiba, LCSW, LCADC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 | |
Elizabeth Brodie, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 91 Avondale Ln, Aberdeen, NJ 07747 Phone: 732-372-8589 | |
Magan Lee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1323 Highway 34, Suite D, Aberdeen, NJ 07747 Phone: 732-598-6202 | |
Victoria Nicole Larsen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1088 State Route 34, Aberdeen, NJ 07747 Phone: 732-290-1700 | |
Ashley Schiraldi, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 |